KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Restructuring Costs: 2015-2025

Historic Restructuring Costs for Arbutus Biopharma (ABUS) over the last 3 years, with Sep 2025 value amounting to $98,000.

  • Arbutus Biopharma's Restructuring Costs fell 97.30% to $98,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 234.89%. This contributed to the annual value of $3.7 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Arbutus Biopharma reported Restructuring Costs of $98,000 as of Q3 2025, which was down 51.00% from $200,000 recorded in Q2 2025.
  • Over the past 5 years, Arbutus Biopharma's Restructuring Costs peaked at $12.4 million during Q1 2025, and registered a low of $95,000 during Q4 2024.
  • Its 2-year average for Restructuring Costs is $3.3 million, with a median of $200,000 in 2025.
  • Data for Arbutus Biopharma's Restructuring Costs shows a maximum YoY slumped of 97.30% (in 2025) over the last 5 years.
  • Arbutus Biopharma's Restructuring Costs (Quarterly) stood at $95,000 in 2024, then tumbled by 97.30% to $98,000 in 2025.
  • Its Restructuring Costs stands at $98,000 for Q3 2025, versus $200,000 for Q2 2025 and $12.4 million for Q1 2025.